Ekso Bionics Reports Record Annual Revenue of $18.3 Million
04 mars 2024 16h05 HE
|
Ekso Bionics Holdings, Inc.
Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in...
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
26 févr. 2024 08h00 HE
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces $4.6 Million Registered Direct Offering
11 janv. 2024 08h00 HE
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Launches GaitCoach Software for EksoNR
08 janv. 2024 16h05 HE
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
04 janv. 2024 17h05 HE
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal
12 déc. 2023 08h00 HE
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29
16 nov. 2023 16h05 HE
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
02 nov. 2023 16h01 HE
|
Ekso Bionics Holdings, Inc.
Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
26 oct. 2023 16h05 HE
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
19 oct. 2023 16h05 HE
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...